Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Esther, Gómez Lanza"'
Publikováno v:
Life, Vol 14, Iss 4, p 464 (2024)
Background. A prospective, descriptive, and multicenter research that included 1104 women with three or more uncomplicated UTIs following immunoprophylaxis with Uromune® vaccine between 2011 and 2022 is presented. Methods. Objective: to analyze the
Externí odkaz:
https://doaj.org/article/02a935bedaaf4f7b9beaf7e72a5f8717
Autor:
Cristóbal Ramírez Sevilla, Esther Gómez Lanza, Juan Llopis Manzanera, Jose Antonio Romero Martín, Miguel Ángel Barranco Sanz
Publikováno v:
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
Abstract Background To prospectively analyze the efficacy of uromune® in the prevention of uncomplicated recurrent urinary tract infections at 3 and 6 months, and according to gender and menopause. Methods From September 2011 to December 2017 uromun
Externí odkaz:
https://doaj.org/article/7d8d78c1e6644cf28850929e3490586b
Publikováno v:
Revista Mexicana de Urología. 82:1-8
Introduction: This study analyzed patients with metabolic syndrome and smokers treated with MV140 vaccine to prevent recurrent UTI. Material and methods: 342 patients with recurrent UTI received MV140 vaccine between 2017 and 2020 in Barcelona, Spain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bfe7662dd2a401817f374c4dd0fab2ba
https://doi.org/10.48193/revistamexicanadeurologa.v82i6.959
https://doi.org/10.48193/revistamexicanadeurologa.v82i6.959
Autor:
Cristóbal Ramírez Sevilla, Esther Gómez Lanza, Juan Llopis Manzanera, Juan Antonio Romero Martin, Miguel Ángel Barranco Sanz
Publikováno v:
Insights Into Incontinence and the Pelvic Floor ISBN: 9783030941734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f3c9308ccd9137e2ed704d942a9e67a0
https://doi.org/10.1007/978-3-030-94174-1_28
https://doi.org/10.1007/978-3-030-94174-1_28
Autor:
Cristóbal Ramírez Sevilla, Esther Gómez Lanza, Juan Llopis Manzanera, Juan Antonio Romero Martin, Miguel Ángel Barranco Sanz
Publikováno v:
Insights Into Incontinence and the Pelvic Floor ISBN: 9783030941734
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5742b672d4e99d0d12e68d77cda36ae
https://doi.org/10.1007/978-3-030-94174-1_27
https://doi.org/10.1007/978-3-030-94174-1_27
Autor:
Cristóbal, Ramírez Sevilla, Esther, Gómez Lanza, Juan, Llopis Manzanera, Alfredo, Cetina Herrando, Josep Miquel, Puyol Pallàs
Publikováno v:
Archivos Españoles de Urología. 75:753
The objective of this article was to assess the long-term efficacy and safety of the MV140 vaccine to prevent recurrent urinary tract infections (UTIs).This is a prospective, descriptive, comparative and multicenter study of 1003 patients with 3 or m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08cb1dca2063906b3a75741bb9a8f2ba
https://doi.org/10.56434/j.arch.esp.urol.20227509.110
https://doi.org/10.56434/j.arch.esp.urol.20227509.110
Autor:
Juan Llopis Manzanera, Cristóbal Ramírez Sevilla, Jose Antonio Romero Martín, Miguel Angel Barranco Sanz, Esther Gómez Lanza
Publikováno v:
BMC Infectious Diseases
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
BMC Infectious Diseases, Vol 19, Iss 1, Pp 1-7 (2019)
Background To prospectively analyze the efficacy of uromune® in the prevention of uncomplicated recurrent urinary tract infections at 3 and 6 months, and according to gender and menopause. Methods From September 2011 to December 2017 uromune® was a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4e9f597e517a8b89aafc2b486225eb7d
https://pubmed.ncbi.nlm.nih.gov/31660885
https://pubmed.ncbi.nlm.nih.gov/31660885
Publikováno v:
Clinical Research in Urology. 2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::33dd27402bf1549045ad8c9d9e15e9c2
https://doi.org/10.33309/2638-7670.020202
https://doi.org/10.33309/2638-7670.020202
Publikováno v:
Archivos espanoles de urologia. 62(10)
Urinary incontinente is an existent complication secondary to the treatment of prostate cancer. It has a difficult management when medical or surgical treatment have not been effective.The objective is to describe pelvic floor training and to explain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::d879b22af8b47d0e4740038de63b913c
https://pubmed.ncbi.nlm.nih.gov/20068266
https://pubmed.ncbi.nlm.nih.gov/20068266
Publikováno v:
Archivos Españoles de Urología (Ed. impresa) v.62 n.10 2009
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
SciELO España. Revistas Científicas Españolas de Ciencias de la Salud
instname
Urinary incontinente is an existent complication secondary to the treatment of prostate cancer. It has a difficult management when medical or surgical treatment have not been effective.The objective is to describe pelvic floor training and to explain
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f5402bc3b842e598b7909794bc81530e
https://doi.org/10.4321/s0004-06142009001000014
https://doi.org/10.4321/s0004-06142009001000014